ArticleFrontiers in transplantation2026
From prediction to practice: artificial intelligence as an enabling layer in liver transplant care - reflections on ILTS 2025.
Article in Frontiers in transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Liver transplantation has become increasingly complex and data-intensive, demanding rapid, high-stakes clinical decisions as patient and organ conditions evolve. The surge of multidimensional clinical datasets has sparked strong interest in artificial intelligence (AI) and machine-learning (ML) as decision-support tools. The 2025 International Liver Transplantation Society (ILTS) annual meeting in Singapore highlighted that AI is now permeating every facet of liver transplantation, from donor-recipient matching and intra-operative navigation to post-transplant pharmacologic management. Early-stage models have shown impressive predictive performance in risk stratification for rejection, infection, and postoperative complications, as well as in individualized immunosuppression dosing and AI-assisted imaging/histopathology. However, real-world implementation has exposed persistent obstacles: data silos, limited generalizability, suboptimal explainability, and workflow friction that can erode clinician trust. Poor integration into existing clinical workflows may also increase cognitive burden for clinicians and reduce adoption of otherwise promising tools. This perspective synthesizes the ILTS 2025 messages and recent transplant literature, proposing a pragmatic three-stage roadmap for AI adoption over the next five years. The roadmap moves from near-term, well-validated decision-support alerts integrated into electronic health records, through mid-term hybrid human-AI teams that embed explainable AI (XAI) into clinical workflows, to long-term global AI consortia that foster federated learning and equitable model deployment. Central to this vision is a shift from "AI as an autonomous decision-maker" to "augmented intelligence that amplifies human expertise while remaining transparent and equitable," ensuring that AI serves as an enabling layer that augments, rather than replaces, clinical judgment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.